CN104434831A - Glipizide composition freeze-dried tablet and preparation method thereof - Google Patents
Glipizide composition freeze-dried tablet and preparation method thereof Download PDFInfo
- Publication number
- CN104434831A CN104434831A CN201410736488.4A CN201410736488A CN104434831A CN 104434831 A CN104434831 A CN 104434831A CN 201410736488 A CN201410736488 A CN 201410736488A CN 104434831 A CN104434831 A CN 104434831A
- Authority
- CN
- China
- Prior art keywords
- glipizide
- tablet
- solution
- composition freeze
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides a glipizide composition freeze-dried tablet and a preparation method thereof, and relates to the technical field of medicine production. The glipizide composition freeze-dried tablet consists of glipizide, starch and sucrose, wherein the starch and the sucrose are used as accessories; the normal corn starch is subjected to heating process treatment, so that the bonding and disintegration effects of the starch in the tablet are enhanced, and the formability of the tablet is improved; only two accessories, namely the starch and the sucrose, are required by the glipizide composition freeze-dried tablet. By virtue of a twice-heating and twice-cooling freeze-drying process, the glipizide composition freeze-dried tablet has better formability due to the process of cooling twice and heating twice, and the dissolution rate of the tablet is improved, so that the bioavailability of the tablet is improved; the tablet is capable of overcoming the shortcomings of a normal glipizide tablet and reducing the variety and dosage of accessories in the glipizide tablet; and the tablet is high in dissolution rate and bioavailability, so that the curative effect and safety of clinical medication are guaranteed.
Description
Technical field
The present invention relates to medicine and medical production technical field, be specifically related to a kind of glipizide composition freeze-drying sheet and preparation method thereof.
Background technology
Glipizide is mainly used in light, the moderate non-insulin-depending type patient that the treatment of alone diet control fails to reach good result; Though past insulinize, daily requirement amount is 30 ~ 40 following persons of unit; To asymptomatic patient, diet control basis still has remarkable hyperglycemia.
Structural formula:
Molecular weight: 445.54
In common glipizide tablet containing supplementary product kind and quantity more, generally to use filler, lubricant, disintegrating agent, adhesive, correctives etc., according to Chinese Pharmacopoeia (2010 editions) second glipizide tablet quality standard, the dissolution of glipizide tablet reached more than 80% for qualified 30 minutes time, and increasing research shows that impurity in the incompatibility of the toxic and side effects of adjuvant itself, adjuvant and principal agent, adjuvant etc. all can have an impact to the safety of medicine.
Therefore, provide one can overcome above-mentioned shortcoming, select suitable adjuvant and technique, reduce supplementary product kind and consumption in glipizide tablet, improve dissolution and the bioavailability of glipizide tablet, ensure that the safety of clinical application all has positive effect.
Traditional lyophilizing tablet can improve dissolution and bioavailability, but still need use the adjuvant such as mannitol, gelatin.And mannitol has certain biological activity, gelatin resource-constrained and perishable.
Starch is the basic adjuvant of oral solid formulation, it is polymerized by glucose molecule, and be commonly used for adhesive, diluent and disintegrating agent in tablets, it is cheap and easy to get, to human-body safety, but being used alone starch has no report as adjuvant freeze-dry process production glipizide lyophilizing sheet.
Summary of the invention
Technical problem to be solved by this invention is the defect overcoming prior art, and propose a kind of glipizide composition freeze-drying sheet and preparation method thereof further, said preparation adjuvant is few, good stability, and bioavailability is high.
Technical problem to be solved by this invention realizes by the following technical solutions:
A kind of glipizide composition freeze-drying sheet, adjuvant is done with starch and sucrose, produce with freeze-dry process, this tablet overcomes the shortcoming of above-mentioned common glipizide tablet, decrease supplementary product kind and consumption in glipizide tablet, this sheet dissolution is large, and bioavailability is high, ensure that curative effect and the safety of clinical application.
A kind of glipizide composition freeze-drying sheet, is prepared from by following raw material:
A preparation method for glipizide composition freeze-drying sheet, comprises step as follows:
A, take the starch of component amount, add a certain amount of purified water and stir, by pH adjusting agent, the pH value of solution is controlled between 5-7.5, be then heated to 72 DEG C, be incubated 20 minutes, make the corn starch solution of 5 ~ 15% (W/V);
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution;
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, is down to room temperature and obtains Semen Maydis-sucrose solution;
D, take glipizide 2.5 grams, add in 1L Semen Maydis-sucrose solution, stir 25 ~ 35 minutes;
Medicinal liquid is sub-packed in drug-containing dish after measuring glipizide content by E, medicinal liquid, each drug-containing dish dress 1.0ml;
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs; Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain glipizide composition freeze-drying sheet.
Described starch selects corn starch, preferably the corn starch solution of 10% (W/V).
Beneficial effect of the present invention is:
The preparation method of a kind of glipizide composition freeze-drying sheet of the present invention, heating process process is carried out to common corn starch, starch bonding in tablets, disintegration can be improved, improve the mouldability of tablet, in glipizide composition freeze-drying sheet, dosage of sucrose is 8.5% (W/V), it is the hardness reinforcer of this tablet, and plays flavored action.Glipizide composition freeze-drying sheet only needs starch and sucrose two kinds of adjuvants.The freeze-dry process of two liters falls in glipizide composition freeze-drying sheet employing two, and twice cooling, twice intensification can make sheet mouldability better, which increase the dissolution of tablet, thus improve the bioavailability of tablet.
Accompanying drawing explanation
Fig. 1 is the dissolution correlation curve figure of furosemide in experiment.
Detailed description of the invention
The technological means realized to make the present invention, creation characteristic, reaching object and effect is easy to understand, below in conjunction with specific embodiment, set forth the present invention further, but following embodiment being only the preferred embodiments of the present invention, and not all.Based on the embodiment in embodiment, those skilled in the art under the prerequisite not making creative work obtain other embodiment, all belong to the protection domain of this patent.
Embodiment 1
A, take the corn starch of 100g, the purified water adding 900ml stirs, and controls at 5-7.5, is then heated to 72 DEG C, keep 120 minutes, make the corn starch solution of 9% (W/V) by pH adjusting agent by the pH value of solution.
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution.
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, after solution be down to room temperature obtain Semen Maydis-sucrose solution.
D, take glipizide 2.5g, add in 1L Semen Maydis-sucrose solution, stir 30 minutes.
Medicinal liquid is sub-packed in drug-containing dish after measuring glipizide content by E, medicinal liquid, each drug-containing dish dress 1.0ml.
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs.Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain glipizide composition freeze-drying sheet.
Embodiment 2
A, take the corn starch of 130g, the purified water adding 900ml stirs, and controls at 5-7.5, is then heated to 72 DEG C, keep 120 minutes, make the corn starch solution of 13% (W/V) by pH adjusting agent by the pH value of solution.
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution.
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, after solution be down to room temperature obtain Semen Maydis-sucrose solution.
D, take glipizide 2.5 grams (by 1000 calculations), add 1L Semen Maydis-sucrose solution, stir 30 minutes.
Medicinal liquid is sub-packed in drug-containing dish after measuring glipizide content by E, medicinal liquid, each drug-containing dish dress 1.0ml.
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs.Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain glipizide composition freeze-drying sheet.
Experimental data
The glipizide composition freeze-drying sheet that above-described embodiment is obtained carries out following quality research test:
1, hardness, friability contrast test
Get glipizide composition freeze-drying sheet prepared by above-described embodiment respectively and glipizide ordinary tablet (commercially available) detects friability and hardness by " Chinese Pharmacopoeia " version in 2010 two annex X G inspection techniques, carried out comparative study, the results are shown in following table:
Sample | Hardness/N | Friability |
Execute example 1 | 66.5 | <1% |
Execute example 2 | 64.6 | <1% |
Ordinary tablet | 74 | <1% |
Experimental data shows, glipizide composition freeze-drying sheet and ordinary tablet (commercially available) without significant difference, meet " Chinese Pharmacopoeia " version in 2010 to the requirement of tablet on friability and hardness.
2, dissolution contrast test
(No. 1 to No. 3 is embodiment 1 to get glipizide tablet (commercially available) and each 6 of glipizide composition freeze-drying sheet, No. 4 to No. 6 is embodiment 2), press Chinese Pharmacopoeia (2010 editions) second dissolution method annex X C first method respectively, with phosphate buffer (pH7.4) 500mL for dissolution medium, rotating speed is 100 turns per minute, operate in accordance with the law, respectively through 5min, 10min, 20min, 30min, during 60min, get solution to filter, get continuous worry liquid, according to Chinese Pharmacopoeia (2010 editions) second annex IV A ultraviolet visible spectrophotometry, absorbance is measured at the wavelength place of 222nm, another precision takes glipizide reference substance and is about 20mg, put in 200mL measuring bottle, add methanol 20ml, jolting makes dissolving, scale is diluted to phosphate buffer (pH7.4), shake up, precision measures 5mL, puts in 100mL measuring bottle, scale is diluted to phosphate buffer (pH7.4), shake up, be measured in the same method, calculate the stripping quantity of every sheet.Result is as follows:
One, glipizide tablet (commercially available)
Two, glipizide lyophilizing sheet (No. 1 to No. 3 is embodiment 1, and No. 4 to No. 6 is embodiment 2)
Respectively with catch cropping Dissolution profiles during average dissolution pair, as Fig. 1.
Four, result judges
Judge according to Chinese Pharmacopoeia (2010 editions) second glipizide tablet quality standard, the dissolution of glipizide tablet (commercially available) reached more than 80% for qualified 30 minutes time, actual measurement is 82.5%, and glipizide lyophilizing sheet dissolution 10 minutes time reaches 81.1%.It can thus be appreciated that the time that glipizide lyophilizing sheet dissolution reaches 80% decreased for about 66.7% (20 minutes) time than glipizide tablet (commercially available).So the glipizide lyophilizing sheet blood drug level peaking time is shorter than glipizide tablet (commercially available), and bioavailability is higher, better efficacy.
More than show and describe ultimate principle of the present invention, principal character and advantage of the present invention.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; what describe in above-described embodiment and description is only preference of the present invention; be not used for limiting the present invention; without departing from the spirit and scope of the present invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the claimed scope of the invention.Application claims protection domain is defined by appending claims and equivalent thereof.
Claims (2)
1. a glipizide composition freeze-drying sheet, is characterized in that, is prepared from by following raw material:
2. a preparation method for glipizide composition freeze-drying sheet according to claim 1, is characterized in that, comprise step as follows:
A, take the starch of component amount, add a certain amount of purified water and stir, by pH adjusting agent, the pH value of solution is controlled between 5-7.5, be then heated to 72 DEG C, be incubated 20 minutes, make the corn starch solution of 5 ~ 15% (W/V);
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution;
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, is down to room temperature and obtains Semen Maydis-sucrose solution;
D, take glipizide 2.5 grams, add in 1L Semen Maydis-sucrose solution, stir 25 ~ 35 minutes;
Medicinal liquid is sub-packed in drug-containing dish after measuring glipizide content by E, medicinal liquid, each drug-containing dish dress 1.0ml;
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs; Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain glipizide composition freeze-drying sheet.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410736488.4A CN104434831A (en) | 2014-12-05 | 2014-12-05 | Glipizide composition freeze-dried tablet and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410736488.4A CN104434831A (en) | 2014-12-05 | 2014-12-05 | Glipizide composition freeze-dried tablet and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104434831A true CN104434831A (en) | 2015-03-25 |
Family
ID=52882099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410736488.4A Pending CN104434831A (en) | 2014-12-05 | 2014-12-05 | Glipizide composition freeze-dried tablet and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104434831A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61242556A (en) * | 1985-04-19 | 1986-10-28 | Hatoya Seika:Kk | Preparation of snack using fruits |
US20020173016A1 (en) * | 2001-03-27 | 2002-11-21 | Helmut Wurst | High-throughput nucleic acid polymerase devices and methods for their use |
CN101134021A (en) * | 2006-08-31 | 2008-03-05 | 海南海灵制药厂有限公司 | Glipizide oral cavity disintegrating lyophilized tablets and method for preparing the same |
-
2014
- 2014-12-05 CN CN201410736488.4A patent/CN104434831A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61242556A (en) * | 1985-04-19 | 1986-10-28 | Hatoya Seika:Kk | Preparation of snack using fruits |
US20020173016A1 (en) * | 2001-03-27 | 2002-11-21 | Helmut Wurst | High-throughput nucleic acid polymerase devices and methods for their use |
CN101134021A (en) * | 2006-08-31 | 2008-03-05 | 海南海灵制药厂有限公司 | Glipizide oral cavity disintegrating lyophilized tablets and method for preparing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104490750A (en) | Spirolactone composition freeze-dried tablets and preparation method thereof | |
CN104490759A (en) | Cobamamide composition freeze-dried tablets and preparation method thereof | |
CN104546766A (en) | Mercaptopurine composition freeze-drying tablet and preparation method thereof | |
CN104586793A (en) | Diazepam composition freeze-dried tablet and preparation method thereof | |
CN104490751A (en) | Hydrochlorothiazide composition freeze-dried tablets and preparation method thereof | |
CN104434831A (en) | Glipizide composition freeze-dried tablet and preparation method thereof | |
CN104586749A (en) | Metronidazole composition freeze-dried tablet and preparation method thereof | |
CN104546683A (en) | Carbocisteine composition freeze-drying tablet and preparation method thereof | |
CN104490754A (en) | Lyophilized tablet prepared from captopril composition and preparation method thereof | |
CN104546767A (en) | Fosfomycin calcium composition freeze-dried tablet and preparation method thereof | |
CN104490831A (en) | Ferrous sulfate composition freeze-dried tablets and preparation method thereof | |
CN104546676A (en) | Cimetidine composition freeze-drying tablet and preparation method thereof | |
CN104490830A (en) | Bezafibrate composition freeze-dried tablet and preparation method thereof | |
CN104546675A (en) | Estazolam composition freeze-dried tablet and preparation method thereof | |
CN104546859A (en) | Dimenhydrinate composition freeze-dried tablets and preparation method thereof | |
CN104523614A (en) | Vitamin B6 composition freeze-dried tablet and preparation method thereof | |
CN104586746A (en) | Propylthiouracil composition freeze-dried tablet and preparation method thereof | |
CN104490758A (en) | Leflunomide composition freeze-dried tablets and preparation method thereof | |
CN104546759A (en) | Primidone composition lyophilized tablet and preparation method thereof | |
CN104434833A (en) | Melbine composition freeze-dried tablet and preparation method thereof | |
CN104586748A (en) | Levofloxacin composition freeze-dried tablet as well as preparation method thereof | |
CN104606157A (en) | Isoniazide composition lyophilized tablet and preparation method thereof | |
CN104606156A (en) | Diethylstilbestrol composition lyophilized tablet and preparation method thereof | |
CN104490821A (en) | Indapamide composition freeze-dried tablet and preparation method thereof | |
CN104434775A (en) | Carvedilol composition freeze-dried tablet and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150325 |